Stay updated with breaking news from Celcuity Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Celcuity Inc. (NASDAQ:CELC – Get Free Report) was the recipient of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 481,400 shares, an increase of 27.8% from the November 30th total of 376,800 shares. Based on an average daily volume of 80,400 shares, the […]
HC Wainwright began coverage on shares of Celcuity (NASDAQ:CELC – Get Free Report) in a research report issued on Friday, Marketbeat.com reports. The firm set a “buy” rating and a $27.00 price target on the stock. HC Wainwright’s target price suggests a potential upside of 82.68% from the company’s current price. Separately, Needham & Company […]
Commodore Capital LP lifted its holdings in shares of Celcuity Inc. (NASDAQ:CELC – Free Report) by 3.8% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,444,141 shares of the company’s stock after buying an additional 53,369 shares during the period. […]
Celcuity Inc. (NASDAQ:CELC – Get Free Report) was the target of a significant drop in short interest during the month of November. As of November 15th, there was short interest totalling 366,900 shares, a drop of 10.6% from the October 31st total of 410,300 shares. Based on an average trading volume of 61,300 shares, the […]
Celcuity (NASDAQ:CELC – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk. Valuation and Earnings This table compares Celcuity […]